Correction: Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells
Abstract
Correction for ‘Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells’ by Lingling Xu et al., RSC Adv., 2022, 12, 18004–18011. https://doi.org/10.1039/D2RA02301F.